BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Lung cancer
,
Retina
,
Early pregnancy factor
,
Aspirin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Egln1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A Case-Control Study of the Associations between EGLN1 Gene Polymorphisms and COPD.
EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of Treatment.
Critical insights on "Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severi…
A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation …
Oxygen enhances antiviral innate immunity through maintenance of EGLN1-catalyzed proline hydroxylati…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing
Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ